BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29772997)

  • 41. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.
    Deng L; Yang SB; Xu FF; Zhang JH
    J Exp Clin Cancer Res; 2015 Feb; 34(1):18. PubMed ID: 25884472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression.
    Geng YJ; Xie SL; Li Q; Ma J; Wang GY
    J Int Med Res; 2011; 39(6):2119-28. PubMed ID: 22289527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of long noncoding RNAs in hepatocellular carcinoma.
    Shi L; Peng F; Tao Y; Fan X; Li N
    Virus Res; 2016 Sep; 223():131-9. PubMed ID: 27374059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications.
    Shi Q; Chu Q; Zeng Y; Yuan X; Wang J; Zhang Y; Xue C; Li L
    Cell Commun Signal; 2023 Dec; 21(1):359. PubMed ID: 38111040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention?
    Wang Y; Lee CG
    Epigenomics; 2011 Apr; 3(2):235-43. PubMed ID: 22122284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Progress of epigenetics and its therapeutic application in hepatocellular carcinoma].
    Sun LY; Li XY; Sun ZW
    Yi Chuan; 2015 Jun; 37(6):517-27. PubMed ID: 26351047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.
    Moyo B; Nicholson SA; Arbuthnot PB
    Virus Res; 2016 Jan; 212():103-13. PubMed ID: 26239319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Research progress on non-coding RNAs in the molecular pathogenesis of hepatocellular carcinoma].
    Luo Z; Cui W
    Zhonghua Gan Zang Bing Za Zhi; 2018 Oct; 26(10):797-800. PubMed ID: 30481892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer.
    Weng M; Wu D; Yang C; Peng H; Wang G; Wang T; Li X
    Transl Res; 2017 Mar; 181():108-120. PubMed ID: 27810413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
    Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
    Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.
    Jin K; Luo G; Xiao Z; Liu Z; Liu C; Ji S; Xu J; Liu L; Long J; Ni Q; Yu X
    Drug Des Devel Ther; 2015; 9():1247-55. PubMed ID: 25750521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma.
    Shi M; Zhang XY; Yu H; Xiang SH; Xu L; Wei J; Wu Q; Jia R; Wang YG; Lu XJ
    Oncotarget; 2017 Jul; 8(27):44195-44202. PubMed ID: 28496001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma.
    Zhang J; Fan D; Jian Z; Chen GG; Lai PB
    PLoS One; 2015; 10(10):e0141042. PubMed ID: 26492393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
    Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comprehensive review of web-based non-coding RNA resources for cancer research.
    Zheng Y; Liu L; Shukla GC
    Cancer Lett; 2017 Oct; 407():1-8. PubMed ID: 28823961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mechanisms of hepatocellular carcinoma.
    Aravalli RN; Steer CJ; Cressman EN
    Hepatology; 2008 Dec; 48(6):2047-63. PubMed ID: 19003900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.